This has not been the easiest of weeks to be an investor in tech stocks. Sentiment, as I have mentioned, is woeful, and analysts are looking under every bush and rock for negatives. Technical analysis that I have seen, is decidedly negative which is, of course, the outcome of negative sentiment. The cyber security software…

To access this post, you must subscribe.

Read More

UiPath; Nutanix, Pure and Salesforce It’s Thursday, the trading week is half over and there are some notable casualties. UiPath is trading down by about 34% and Salesforce is down by more than 18%. NTNX, which had been “bulled-up” into the numbers, is trading in line with a “sell the news paradigm” and is down…

To access this post, you must subscribe.

Read More

Sale of 100 shares of Crowdstrike at the opening; Sale of 100 shares of DT at the opening; Purchase of 120 shares of CyberArk at the opening, Purchase of 40 shares of Datadog; Comments on the ZS downgrades As we discussed in the portfolio commentary we published yesterday, we are exiting our Crowdstrike position. The…

To access this post, you must subscribe.

Read More

Portfolio changes

Purchase of 60 shares of Snowflake; Sale of 150 shares of Nutanix We added 50 shares of Snowflake (SNOW) to our high growth portfolio today. We previously had 270 shares and we now have 330 shares. At the current price, a 330 share position is a weighting of about 5%. Snowflake shares, after spiking positively…

To access this post, you must subscribe.

Read More

Snowflake reported its Q1-FY 2025 results on the afternoon of May 22. Simply put, the operating results for the quarter were significantly above prior expectations. Most analysts have raised their price targets by between 15%-25%. I wouldn’t be surprised to see some upgrades. That said, the shares are up by around 5% premarket. The reason…

To access this post, you must subscribe.

Read More

Sale of 250 shares of Nutanix; Sale of 100 shares of Dynatrace; purchase of 150 shares of AppLovin; Purchase of 20 shares of CyberArk We made some changes to the high growth portfolio today. In general, my strategy is to hold positions long term. But sometimes, when I see tactical opportunities, I take them. I…

To access this post, you must subscribe.

Read More

Sale of 50 shares of Crowdstrike; Purchase of 80 shares of CyberArk Very reluctantly, we decided to sell 25% of our Crowdstrike position today. Our sale price was $348.49 and the sale raided about $17,415. Crowdstrike shares have risen by more than 18% in the last 3+ weeks. That kind of performance is far greater…

To access this post, you must subscribe.

Read More

Sale of 500 DT shares and purchase of 1000 shares of NU and 30 shares of Datadog We made some portfolio adjustments this morning. We sold 500 shares of Dynatrace at $47.79. We were not pleased with the company’s earnings report-particularly its forward guidance for ARR growth. After a couple of quarters of mentally making…

To access this post, you must subscribe.

Read More

Bought 60 shares of Datadog at $116.69 We added 60 shares of Datadog to our position in the high growth model portfolio at a price of $116.79. After bouncing from post earnings lows, based in part on a new purchase recommendation by the analyst at Baird, the shares have pulled back. For the reasons listed…

To access this post, you must subscribe.

Read More

Summary Datadog reported strong quarterly results, beating estimates and showing accelerated usage growth. Traders were initially unhappy with the company’s guidance, causing a drop in shares. The company’s long-term prospects remain strong, with potential for accelerated revenue growth and increased adoption of its AI solutions. Datadog’s platform strategy is resonating strongly with users. Bookings growth…

To access this post, you must subscribe.

Read More